Teleflex today announced a partnership with Shenzhen Insighters Medical Technology Co., even as its stock took a hit from an analyst downgrade. The partnership makes Teleflex the exclusive U.S. distributor of the Insighters video laryngoscope system. Insighters designed the system to inspect the upper glottic airway and facilitate endotracheal intubation. It features interchangeable accessories and […]
Teleflex
FDA clears Teleflex’s Wattson temporary pacing guidewire
Teleflex (NYSE:TFX) announced today that it received FDA clearance for its Wattson temporary pacing guidewire for use in heart procedures. Wayne, Pennsylvania-based Teleflex says it’s the first commercially available bipolar temporary pacing guidewire designed specifically for use during TAVR and BAV. The company plans to feature Wattson at TVT: The Structural Heart Summit, June 7-10 […]
Teleflex Arrow EZ-IO needle cleared for use in MRI
Teleflex (NYSE:TFX) announced today that it received FDA 510(k) clearance for its Arrow EZ-IO needle for MR conditional labeling. Wayne, Pennsylvania-based Teleflex said the regulatory nod makes the needle the first and only intraosseous needle with 510(k) clearance. The EZ-IO needle represents a critical component of Teleflex’s Arrow EZ-IO intraosseous vascular access system. It features […]
Teleflex signs purchasing agreements with Premier
Teleflex today announced it was awarded two group purchasing agreements with Premier, effective July 1. The new agreements allow Premier members, at their discretion, to use special pricing and terms pre-negotiated by Premier for Teleflex’s central venous and arterial vascular access products. Premier also awarded Teleflex a national agreement for hemodynamic monitoring products and accessories, […]
Teleflex vascular access division drives sales growth in Q1, despite share price drop
Teleflex today announced first-quarter results that beat the overall consensus on Wall Street. The Wayne, Pennsylvania-based company reported profits of $78.7 million, or $1.62 per share, on sales of $710.9 million for the three months ended April 2, for a bottom-line loss of 0.5% and sales growth of 10.79% compared to Q1 2022. Adjusted to […]
Teleflex launches two new PICC insertion devices
Teleflex today announced it launched two new devices to enhance PICC insertion procedures and reduce complications. The company launched the Arrow VPS Rhythm DLX device and the NaviCurve stylet, both of which Teleflex designed to work together to give vascular access specialists more efficient and predictable PICC placement. VPS Rhythm DLX gives physicians real-time catheter […]
Teleflex announces new positive research for UroLift system
Teleflex (NYSE:TFX) today announced new research from multiple studies supporting the prostatic urethral lift (PUL) procedure with its UroLift system. Wayne, Pennsylvania-based Teleflex designed UroLift to treat men with benign prostatic hyperplasia (BPH). It presented data at the 38th Annual European Association of Urology (EAU) Congress in Milan, Italy. The company said in a news […]
Teleflex performance was mixed in Q4
Teleflex (NYSE:TFX) today reported fourth-quarter results that beat the Wall Street consensus on earnings but missed on revenue. Analysts initially described its revenue growth guidance for 2023 as disappointing. The Wayne, Pennsylvania–based maker of critical care and surgical products earned $78.6 million, or $1.66 per share, off $758.0 million for the quarter that ended Dec. […]
Teleflex warns on some intra-aortic balloon pumps
Teleflex (NYSE:TFX) subsidiary Arrow initiated a voluntary field safety corrective action for some intra-aortic balloon pump devices. According to a safety notice issued in Europe, the devices have a potential issue around short battery run times. The devices can be powered by either an AC power source or battery power. As of Oct. 11, 2022, […]
Teleflex announces another round of restructuring
Teleflex (NYSE:TFX) plans another round of restructuring — including manufacturing offshoring — to better position itself for long-term growth. In a Form 8-K filed with the SEC today, the Wayne, Pennsylvania–based maker of critical care and surgical products said it expects to incur $31 million to $40 million in restructuring costs through 2023. About $18 […]
Teleflex has a serious breathing circuit bacterial filters recall
The FDA this week said the Teleflex (NYSE:TFX) recall of some Gibeck Iso-Gard bacterial and viral filters is a Class I recall, the most serious kind. Teleflex is recalling several types of the Iso-Gard Filter S after receiving reports that the filter may split or become detached from breathing systems. Iso-Gard Filter S filters are […]